Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Bioconjugate chemistry

• Publication date

  2005-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BC049730CPMID 16029020PMCID PMC2711208
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Caprine mucopolysaccharidosis IIID

  2007cited by this paper
• Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier.

  2004cited by this paper
• Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible.

  2003cited by this paper
• Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial Cells

  2003cited by this paper
• Passage of vasoactive intestinal peptide across the blood-brain barrier.

  2003cited by this paper
• Strategies for the Delivery of Leptin to the CNS

  2002cited by this paper
• Enzyme replacement and enhancement therapies: lessons from lysosomal disorders

  2002cited by this paper
• Differential Transport of a Secretin Analog across the Blood-Brain and Blood-Cerebrospinal Fluid Barriers of the Mouse

  2002cited by this paper
• Neuroprotective peptide drug delivery and development: potential new therapeutics.

  2001cited by this paper
• Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents

  2000cited by this paper
• A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health.

  1999cited by this paper
• Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide.

  1999cited by this paper
• Pluronic P85 Increases Permeability of a Broad Spectrum of Drugs in Polarized BBMEC and Caco-2 Cell Monolayers

  1999cited by this paper
• Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier.

  1998cited by this paper
• Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.

  1998cited by this paper
• Fatty acid acylated peroxidase as a model for the study of interactions of hydrophobically-modified proteins with mammalian cells.

  1995cited by this paper
• Transport of hydrophobized fragments of antibodies through the blood–brain barrier

  1995cited by this paper
• Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

  1993cited by this paper
• Application of cultured endothelial cells of the brain microvasculature in the study of the blood-brain barrier

  1992cited by this paper
• Fatty acid acylated Fab‐fragments of antibodies to neurospecific proteins as carriers for neuroleptic targeted delivery in brain

  1991cited by this paper
• Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates

  1991cited by this paper
• Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins

  1990cited by this paper
• Lipid modification of proteins and their membrane transport.

  1989cited by this paper
• Transformation of Water‐Soluble Enzymes into Membrane Active Form by Chemical Modification

  1987cited by this paper
• Measurement of protein using bicinchoninic acid.

  1985cited by this paper
• Transport of alpha-aminoisobutyric acid across brain capillary and cellular membranes.

  1983cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

  1983cited by this paper
• An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines.

  1975cited by this paper

• Investigating the Cytosolic Delivery of Proteins by Lipid Nanoparticles Using the Chloroalkane Penetration Assay.

  2024cites this paper
• Peptides in the detection of metal ions.

  2024cites this paper
• Food-Derived Peptides: Beneficial CNS Effects and Cross-BBB Transmission Strategies.

  2023cites this paper
• A Historical Review of Brain Drug Delivery

  2022cites this paper
• Formulation optimization and in vitro characterization of rifampicin and ceftriaxone dual drug loaded niosomes with high energy probe sonication technique

  2020cites this paper
• Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies.

  2020cites this paper
• Applications of nanotechnology in drug delivery to the central nervous system.

  2019cites this paper
• Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles

  2019cites this paper
• Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes

  2019cites this paper
• Recent Advances in the Design of Self‐Delivery Amphiphilic Drugs and Vaccines

  2019cites this paper
• Envisioning the future of polymer therapeutics for brain disorders.

  2018cites this paper
• Partition of Glutamic Acid-Based Single-Chain and Gemini Amphiphiles into Phospholipid Membranes.

  2018cites this paper
• Targeting neuronal nitric oxide synthase by a cell penetrating peptide Tat-LK15/siRNA bioconjugate.

  2017cites this paper
• Iron Oxide Nanoparticle Delivery of Peptides to the Brain: Reversal of Anxiety during Drug Withdrawal

  2017influential citation
• Polymer Nanomaterials for Drug Delivery Across the Blood Brain Barrier

  2017cites this paper
• Development and application of nano-flavor-drug carriers in neurodegenerative diseases

  2017cites this paper
• In vitro screening of nanomedicines through the blood brain barrier: A critical review.

  2016cites this paper
• A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.

  2016cites this paper
• Influence of Tumor Microenvironment on the Distribution and Elimination of Nano-formulations.

  2016cites this paper
• Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.

  2015cites this paper
• Exosomes as drug delivery vehicles for Parkinson's disease therapy.

  2015cites this paper
• Polymer Therapeutics as Nano‐Sized Medicines for Tissue Regeneration and Repair

  2015cites this paper
• Nanomedicinal Approach of Getting Across the Brood-Brain Barrier with Nanomedicinal Nanoparticles.

  2015cites this paper
• Recent progress in biomedical applications of Pluronic (PF127): Pharmaceutical perspectives.

  2015cites this paper
• Thermo-triggered drug release from actively targeting polymer micelles.

  2014cites this paper
• Nanotechnology for the Detection and Therapy of Stroke

  2014cites this paper
• Agile delivery of protein therapeutics to CNS.

  2014cites this paper
• Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating

  2014cites this paper
• Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders.

  2014cites this paper
• Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.

  2014cites this paper
• Colloidal supramolecular aggregates for therapeutic application in neuromedicine.

  2014cites this paper
• Review of Drug Delivery Applications of Pluronics

  2014influential citation
• Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges

  2014cites this paper
• Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

  2014cites this paper
• Strategies to deliver peptide drugs to the brain.

  2014cites this paper
• Synthesis and Characterization of Novel Polyethers and Polypeptides for Use in Biomedicine and Magnetic Resonance Imaging

  2014cites this paper
• Neuropeptides in Alzheimer's disease: from pathophysiological mechanisms to therapeutic opportunities.

  2013cites this paper
• Peptide pills for brain diseases? Reality and future perspectives.

  2013cites this paper
• Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier.

  2013cites this paper
• pH-triggered intracellular release from actively targeting polymer micelles.

  2013cites this paper
• Preclinical evaluation of radiosensitizing activity of Pluronic block copolymers

  2013cites this paper
• Nanofiber-based delivery of therapeutic peptides to the brain.

  2013cites this paper
• Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.

  2013cites this paper
• Microspheres for targeting delivery to brain

  2013cites this paper
• Specific Transfection of Inflamed Brain by Macrophages: A New Therapeutic Strategy for Neurodegenerative Diseases

  2013cites this paper
• Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.

  2013cites this paper
• Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo.

  2013cites this paper
• Brain delivery of proteins via their fatty acid and block copolymer modifications

  2013cites this paper
• Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery.

  2012cites this paper
• Promethazine inhibits NMDA-induced currents - new pharmacological aspects of an old drug.

  2012cites this paper
• A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain.

  2012cites this paper
• Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles.

  2011cites this paper
• Principles of strategic drug delivery to the brain (SDDB): development of anorectic and orexigenic analogs of leptin.

  2011cites this paper
• Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease.

  2011cites this paper
• Drug delivery across the blood-brain barrier

  2011cites this paper
• An investigation of the use of dendrimer-based carrier to cross cellular barrier

  2011cites this paper
• Complex Functional Macromolecules

  2011cites this paper
• Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells.

  2011cites this paper
• Pluronic-based cationic block copolymer for forming pDNA polyplexes with enhanced cellular uptake and improved transfection efficiency.

  2011cites this paper
• Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors.

  2011cites this paper
• Oral peptide therapeutics : the impact of new technologies & clinical development Since the licensing of a vasopressin analog

  2010cites this paper
• Protein modification with amphiphilic block copoly(2-oxazoline)s as a new platform for enhanced cellular delivery.

  2010cites this paper
• The Blood – Brain Barrier and its Effect on Absorption and Distribution

  2010cites this paper
• Nanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and Diagnosis

  2010cites this paper
• The utilization of pathogen-like cellular trafficking by single chain block copolymer.

  2010cites this paper
• In vivo release of bovine serum albumin from a small intestinal submucosa gel

  2010cites this paper
• Synthesis of a novel series of diphenolic chromone derivatives as inhibitors of NO production in LPS-activated RAW264.7 macrophages.

  2010cites this paper
• Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons.

  2010cites this paper
• Transport across the Blood-Brain Barrier of Pluronic Leptin

  2010influential citation
• Various drug delivery approaches to the central nervous system

  2010influential citation
• A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles.

  2009cites this paper
• Influence of polymer adjuvants on the ultrasound-mediated transfection of cells in culture.

  2009cites this paper
• Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.

  2009cites this paper
• Novel Nanomaterials for Clinical Neuroscience

  2008cites this paper
• Drug targeting to the brain

  2008cites this paper
• Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery.

  2008cites this paper
• Preparation and in vitro Evaluation of Linear and Star-branched PLGA Nanoparticles for Insulin Delivery

  2008cites this paper
• Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport.

  2008cites this paper
• Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

  2007influential citation
• Drug Targeting to the Brain

  2007cites this paper
• A macrophage-nanozyme delivery system for Parkinson's disease.

  2007cites this paper
• Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).

  2007cites this paper
• In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.

  2007cites this paper
• Strategies to Improve Drug Delivery Across the Blood-Brain Barrier

  2007cites this paper
• Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

  2006cites this paper
• Design of biocompatible chitosan microgels for targeted pH-mediated intracellular release of cancer therapeutics.

  2006cites this paper